• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

Chemical Profile of 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine (CAS No: 265654-77-1)

1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine, identified by its Chemical Abstracts Service (CAS) number 265654-77-1, is a compound of significant interest in the field of pharmaceutical chemistry and medicinal research. This heterocyclic derivative features a pyrrolidine core linked to an ethyl chain terminated with a phenoxy group, where the phenoxy moiety is further substituted with a nitro group at the para position. The structural configuration of this molecule imparts unique physicochemical properties and biological activities, making it a valuable candidate for further exploration in drug discovery and development.

The nitrophenoxy substituent plays a pivotal role in modulating the electronic and steric environment of the molecule. The nitro group, known for its electron-withdrawing properties, can influence the reactivity and binding affinity of the compound towards biological targets. This feature is particularly relevant in the design of molecules targeting enzymes or receptors that exhibit specific electronic requirements for binding. Additionally, the presence of the pyrrolidine ring contributes to the compound's flexibility and potential for conformational diversity, which can be advantageous in achieving high binding affinity and selectivity.

In recent years, there has been growing interest in exploring novel scaffolds for therapeutic intervention. The 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine structure aligns well with current trends in medicinal chemistry, which favor the incorporation of heterocyclic motifs due to their prevalence in biologically active natural products and approved drugs. The pyrrolidine scaffold, in particular, is widely recognized for its role in various pharmacophores, including GABA receptor modulators, antiviral agents, and anti-inflammatory compounds.

Recent studies have highlighted the potential of nitroaromatic derivatives as pharmacological agents. The nitro group in 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine can undergo reduction to an amine under specific conditions, leading to the formation of new functional groups that may enhance biological activity. This redox chemistry has been exploited in various therapeutic contexts, including cancer therapy and neurodegenerative diseases. The ability to modulate the redox state of this compound could open up new avenues for developing prodrugs or targeted therapeutics.

The ethoxy chain extending from the phenoxy group introduces additional conformational flexibility to the molecule. This feature can be leveraged to optimize interactions with biological targets by adjusting solubility, lipophilicity, and metabolic stability. In drug design, such structural elements are often critical for achieving optimal pharmacokinetic profiles. The ethyl chain also provides a site for further derivatization, allowing chemists to fine-tune the properties of 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine to meet specific therapeutic requirements.

From a synthetic perspective, 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine presents an interesting challenge due to its complex architecture. The synthesis would likely involve multi-step reactions, including nucleophilic substitution reactions to introduce the phenoxy and pyrrolidine moieties, followed by nitration to install the nitro group. Advances in synthetic methodologies have enabled more efficient and scalable production of such complex molecules, making it feasible to pursue their pharmacological evaluation.

The potential applications of 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine are broad and span multiple therapeutic areas. Its structural features suggest utility in developing treatments for neurological disorders, where modulation of neurotransmitter systems is often required. Additionally, its ability to undergo redox transformations makes it a promising candidate for antineoplastic therapies targeting hypoxic or acidic environments within tumors.

In conclusion, 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine (CAS No: 265654-77-1) represents a structurally intriguing compound with significant potential in pharmaceutical research. Its unique combination of heterocyclic motifs and functional groups positions it as a valuable scaffold for developing novel therapeutics. As our understanding of biological targets continues to evolve, compounds like this one will play an increasingly important role in addressing unmet medical needs.

• 92033-76-6(1-(2-(4-Nitrophenoxy)ethyl)piperidine)
• 85002-96-6(1-[2-(4-Nitrophenoxy)ethyl]pyrrolidine--hydrogen chloride (1/1))
• 220728-17-6(1-[5-(4-Nitrophenoxy)pentyl]pyrrolidine)
• 1187930-72-8(3-(4-Nitrophenoxy)pyrrolidine)
• 1286207-30-4((S)-3-(4-Nitrophenoxy)pyrrolidine HCl)
• 92033-81-3(1-(3-(4-Nitrophenoxy)propyl)pyrrolidine)
• 19881-36-8(Diethyl2-(4-nitrophenoxy)ethylamine)
• 170229-91-1(Pyrrolidine, 1-[2-(2-methoxy-5-nitrophenoxy)ethyl]-)
• 946727-05-5(3-(3-NITROPHENOXY)PYRROLIDINE)
• 1187930-80-8(3-(4-nitrophenoxy)pyrrolidine;hydrochloride)